Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
CD20-TARGETED ANTIBODY COUPLING PHARMACEUTICAL PREPARATION
Document Type and Number:
WIPO Patent Application WO/2018/149413
Kind Code:
A1
Abstract:
A CD20-targeted antibody coupling pharmaceutical preparation, specifically a preparation comprising a CD20-targeted antibody coupling medication represented by formula I and an excipient. The antibody coupling pharmaceutical preparation has prominent antitumor effect.

Inventors:
WU YOULING (CN)
ZHANG YUJIE (CN)
LU JIALI (CN)
Application Number:
PCT/CN2018/076835
Publication Date:
August 23, 2018
Filing Date:
February 14, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ZHEJIANG TERUISI PHARMACEUTICAL INC (CN)
International Classes:
A61K47/68; A61K39/395; A61P35/00; C07K5/02
Domestic Patent References:
WO2016008112A12016-01-21
WO2016049214A12016-03-31
WO2015151079A22015-10-08
Foreign References:
US20050180972A12005-08-18
CN1938046A2007-03-28
CN102573908A2012-07-11
Attorney, Agent or Firm:
XU AND PARTNERS, LLC. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: OPTICAL PATH MODIFICATION METHOD, AND METHOD OF MANUFACTURING OPTICAL GRATING FOR MODIFYING OPTICAL ...

Next Patent: OPTICAL IMAGING DEVICE CAPABLE OF POSITIONING PROJECTION